LAG3 and neoplasm: The latter is represented by LAG-3-Ig fusion proteins such as IMP321 or eftilagimod alpha (Immuntep®), a soluble form of LAG-3, induces the co-stimulative molecules and enhances the production of interleukin (IL)-12 to boost tumor immunity [31,55,60].